Generation and purification of bacterially expressed proteins MPK3 and MPK6 were amplified from Arabidopsis cDNA using MPK3F/R and MPK6F/R primer combinations (Table 1) using Accuprime Pfx DNA polymerase (Invitrogen, Carlsbad, CA). Subsequent amplified products were cloned into the pENTR-D-TOPO (Invitrogen, Carlsbad, CA) according to manufacturer's protocols. MPK3F and MPK6F primers were designed to include an in-frame thrombin cleavage site (CTG GTT CCG CGT GGA TCC/ LVPRGS) to allow for subsequent removal of the GST-Tag. Sequences encoding MPK3 and MPK6 and SPCH variants in pENTR were recombined into the E. coli expression vector pDEST15 (Invitrogen, Carlsbad, CA) and transformed into E. coli BL21 cells. GST-tagged proteins were purified batch-style using glutathione-Sepharose 4B beads (GE Healthcare, Piscataway, NJ) following standard procedures. Elution of recombinant protein was carried out using two successive ten minute incubations in one ml elution buffer, pooled and stored at -80°C until further use. Where specified, MPK3 and MPK6 proteins were eluted via cleavage with thrombin protease (GE Healthcare, Piscataway, NJ) for two hours according to manufacturer's protocols.
In vitro Kinase Assays
In vitro kinase assays to assess the ability of MPK3 or MPK6 to phosphorylate specific SPCH variants were performed based on that reported by (9) as follows: 250 ng of recombinant MAPK and 1 µg SPCH variant substrate were diluted to a total volume of 25 µL in 10X kinase buffer (25 mM Tris HCl, pH 7.5; 1 mM EDTA; 1 mM EGTA; 1 mM DTT; 5 mM MgCl 2 ; 25 mM ATP; 5mM β-glycerophosphate; 0.1 mM sodium orthovanadate; 1X protease inhibitor (Sigma-Aldrich, St. Louis, MO)) with MnCl 2 to auto-activate the MAPK (9) . Each reaction was spiked with 5 µCi γ-32 P-ATP (Perkin Elmer, Waltham, MA) and incubated at 30°C for thirty minutes. Reactions were stopped by the addition of 6X Laemmli buffer and incubating at 75°C for ten minutes. Samples were resolved by SDS-PAGE gels and the gels were dried prior to exposure to film to detect incorporation of radioactive label.
Microscopy
DIC images were used for qualitative and quantitative examination of epidermal phenotypes on material cleared in 70% ethanol and then overnight in Hoyer's solution (10) using protocols and equipment in (2) . Confocal images were taken with a Leica SP5 with excitation/emission spectra of 488/505-520 for GFP, 514/520-540 for YFP and 565/580-610 for propidium iodide counterstaining. Images were processed in ImageJ (NIH).
Scoring of phenotypes, rescue and SPCH-GFP/YFP expression patterns.
To assay the effects of SPCH variant expression on development, we aimed to have equivalently expressed lines. To this end, 2.5 KB of the endogenous 5' SPCH sequence was used as a common promoter. However, as expression of some SPCH variants induces the production of cells that express SPCH, it is not possible to find lines with equivalent SPCH RNA or protein expression across all genotypes. We have instead chosen to follow representative lines chosen from at least 12 T2s (and up to 40 lines for some) for each genotype. For each deletion and S/T>A variant two lines with median phenotypes and GFP/YFP expression were chosen for analysis. In the case of Δ93, Δ49, SPCH S/T>A1-5 and SPCH S/T>A1-4, many of the T1 plants were inviable and sterile. At least 24 T1s were also assayed from each of these lines. All phenotypes were scored on equivalently staged plants and images were taken of the basal quadrant of the cotyledon or leaf in the region between the midvein and leaf margin. For scoring phenotypes in Fig 3 , cells in 6-12 0.25 mm 2 regions were counted for each genotype and the means calculated. Following confirmation of normality by normal probability plots, the data were subjected to one-way analysis of variance using the R statistical computing software, p-value=7.845e-15 for non-stomatal cells and 1.916e-14 for stomata. Significant differences between the full length SPCH values and each of the constructs were determined using Dunnett's test with a joint confidence coefficient of P=99% (11) .
The effect of SPCH and Δ49 expression in sdd1 and erl1;erl2 was quantified for 5 0.25mm 2 regions by determining the stomatal density and fraction of stomata in direct contact. Significant differences were determined by analysis of variance as above and Tukey's HSD test. The addition of the transgenes did not significantly change these values in the sdd1 background, but they were significantly higher in the erl1;erl2 background. Suppression of tmm-1; SPCHpro::SPCH-GFP by CA-YODA was assayed by crossing tmm-1; SPCHpro::SPCH-GFP; E1728 (2) to CA-YDA/+. In the F2 generation, SPCHpro::SPCH-GFP; E1728 was selected for on HygromycinB/Kanamycin plates. Resistant seedlings were scored for excessive hypocotyl stomata (the phenotype of tmm-1; SPCHpro::SPCH-GFP). 12 seedlings with this phenotype were selected, planted and scored for the presence of CA-YDA after bolting. None of the 12 carried the CA-YDA transgene. 35S::GFP-SPCH and 35S::GFP-SPCHΔ49 were introduced into the CA-YDA background by Agrobacterium mediated transformation of heterozygous CA-YDA plants. Transformants were selected on HygromycinB. T2 seedlings were scored for CA-YDA by the absence of stomata as well as by the additional CA-YDA phenotypes including short roots and fused and supernumerary cotyledons.
Ability to rescue the null spch-3 phenotype was assayed by transformation of the construct in question into a spch-3 heterozygous background. Lines segregating the spch-3 phenotype were identified by microscopic examination of 10-14 dpg cleared T2s and the number of wild type and spch mutant phenotype seedlings (seedlings devoid of stomata) was counted. These results were analyzed using the R statistical analysis software by chi-squared test. If the construct failed to rescue the stomatal production defect in spch-3 the expected segregation ratio for the mutant phenotype would be 0.25, this would be reduced to 0.0625 if the construct is able to rescue. The full length SPCH under both 35S and native promoters was previously shown to rescue the spch-3 mutation (2). All rescue data reported in Fig. S6 were significant (p ≤ 0.05) and at least 2 (usually 4) T2 lines were tested for each construct. Both the ability to make stomata and the ability to undergo asymmetric cell divisions were assayed by the appearance of cells in 10-14 dpg cotyledons and leaves.
Identification of PEST domain. SPCH protein was run through tools on the online PEST domain prediction site http://www.at.embnet.org/toolbox/pestfind. A score of +5 or higher in from this program is considered a strong prediction of a PEST domain.
Mass Spectrometry
Following in vitro kinase assays between MPK3 and SPCH MPKTD or MPK6 and SPCH MPKTD, proteins were separated by SDS-PAGE and coomassie stained gel bands of the SPCH MPKTD protein were excised and digested using trypsin as in (12) with the additional use of a MS friendly surfactant (Protease Max, Promega, WI.). For the enriched phosphopeptide LC MSMS runs, the extracted peptides were enriched using a swellgel gallium metal phosphopetide enrichment kit commercially available (Thermo Scientific, Waltham, MA). The enrichment procedure was followed as suggested, with the only exception in that the enrichment buffer contained 2% lactic acid (w/v) (13) . The digest was done in triplicate with three different gel bands. Each of these digests was run in duplicate providing 6 LC MSMS runs all providing consistent results and phosphopeptide determination. Nano reversed phase HPLC was done using an Eksigent 2D nanoLC (Eksigent, Dublin, CA) with buffer A consisting of 0.1 % formic acid in water and buffer B 0.1 % formic acid in acetonitrile. A fused silica column self packed with duragel C18 (Peeke, Redwood City, CA) matrix was used with a linear gradient from 5 % B to 40 % B over 60 minutes at a flow rate of 450 nL/minute. The nanoHPLC was interfaced with an Advion Nanomate (Ithaca, NY) for nanoESI into the mass spectrometer. The mass spectrometer was a LCQ Deca XP Plus (Thermo Scientific) which was set in data dependent acquisition mode to perform MS/MS on the top three most intense ions with a dynamic exclusion setting of two. The DTA files were extracted from the raw data using the bioworks browser (Thermo Scientific). Because the gel bands only contained truncated SPCH protein and the activating kinase, the SPCH sequence was specifically searched using Sequest allowing for oxidation on methionine and phosphorylation on serine, threonine and tyrosine amino acids. All peptides with a XCorr less than 2.5 were discarded. Additionally, the same extracted DTA files were searched against the NCBI Arabidopsis thaliana database using Mascot allowing for the same fore mentioned modifications. In most cases
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Analysis of Mass Spectrometry Data
The SPCH MPKTD was subjected to in vitro kinase assays in combination with either MPK3 or MPK6 as previously described with the exception that 200 μM ATP was used in place of 32 P-ATP. Following separation by SDS-PAGE and excision of coomassie stained bands containing SPCH MPKTD, tryptic peptides were examined to identify specific residues that were phosphorylated. Peptides containing three out of the five high stringency MAPK targets sites (sites 1-3) were identified by these analyses methods and each site is phosphorylated by MPK3 and/or MPK6. Site 1 was identified only in MPK6 analyses due to the presence of miscleaved tryptic peptides that were not found in the MPK3 samples. Thus, there are no data pertaining to the ability of MPK3 to phosphorylate site 1. Similarly, phosphorylation data for site 3 was retrieved from miscleaved peptides found only in MPK3 containing assays. Site 4 is situated on a peptide that is too short to be identified; it is found on miscleaved peptides, however, on these it is situated too close to the cleavage site to obtain reliable phosphorylation data. Conversely, site 5 is situated on a peptide too long to be detected. Phosphorylation of additional -SP-motifs (S177 by MPK3 and S186 by both MPK3 and MPK6) was also detected, explaining the ability to detect 32 P incorporation in in vitro kinase assays examining the ability of MPK3 or MPK6 to phosphorylate the SPCH 1-5 S/T>A variant. (blue) and MPK6 (red) were found to be phosphorylated on multiple high stringency residues (denoted by asterisks). Putative PEST domain is shown in italics. High stringency sites are: site 1 -S193, site 2 -S211, site 3 -T214, site 4 -S219 and site 5 -S255. For a complete explanation of results, see supplemental text. B) The MSMS spectra of the doubly phosphorylated triply charged SPCH peptide V174-R195. The mis-cleavage at R188 and K189 (P both N-and Cterminal to these residues) was an advantage in identifying the phosphorylation sites at both S186 and S193. The MSMS spectra clearly show prominent mono and di-phospho losses. Additionally the y ion series, particularly y 10 confirms the localized serine phosphorylation sites. C) MSMS of the triply charged cation SPCH peptide I196-R213. The neutral loss is apparent, only one possible phosphorylation site is present (S211) which is confirmed by the fragment ion series. D) MSMS spectra of the mis-cleaved SPCH peptide I196-R222. The peptide was selected and fragmented as a triply charged cation. Double and single phospho losses are prominent. S211 was confirmed phosphorylated in C, it is reconfirmed here as well as the T214. Two other potential C-terminal phosphorylation sites exist (T218, S219) but the y ion series confirms the sites as S211 and T214. . This basal activity results in SPCH being phosphorylated on site 1, which renders it active, but also on the negative regulatory sites 2-5 residues, limiting its activity to a short time period. Phosphorylation on these sites could result in inactivation of SPCH by promoting protein degradation or alternatively by altering the ability of SPCH to interact with additional stomatal regulators such as ICE1/SCREAM and/or SCREAM2. MAPK modules independent of the stomatal development module (YODA MKK4/5 MPK3/6) that converge on MPK3 and MPK6 can be activated by several types of upstream stimuli and this allows for fine tuning of stomatal development in response to altered biological conditions. According to this model, during acute exposure to upstream activators (e.g. pathogen attack) hyperactivation of MPK3 and MPK6 can trigger a rapid inactivation of SPCH, allowing for a reallocation of resources from developmental mechanisms to stress-tolerance, whereas in response to competing environmental demands (CO 2 levels, light, humidity) SPCH may be more or less phosphorylated allowing for alterations in SPCH activity and subtle modulation of stomatal and epidermal development programs. Potential MAPK phosphorylation sites are in orange and a box surrounds high stringency sites, numbering of the high stringency sites for SPCH is as in Fig.1A . Perfectly conserved sites are marked with '*', conserved sites with ':' and semi-conserved sites with '.'. The alignment begins after the bHLH domain. The start of the Cterminal domain is in green. TIGR database sequence identifiers are as follows: RcSPCH, 30169.m006534; ZmSPCH A, AZM5_15260; ZmSPCH B, AZM5_13800. The locus identifier for OsSPCH A is Os06g33450 and for OsSPCH B is Os02g15760. The sequence alignment was generated by ClustalW using default parameters.
SPCH variant
